Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023

SELL
$7.35 - $13.21 $5,145 - $9,247
-700 Reduced 4.77%
13,973 $102,000
Q1 2023

May 04, 2023

SELL
$7.79 - $16.29 $311 - $651
-40 Reduced 0.27%
14,673 $152,000
Q4 2022

Jan 26, 2023

SELL
$11.0 - $21.45 $275 - $536
-25 Reduced 0.17%
14,713 $0
Q3 2022

Nov 01, 2022

BUY
$20.09 - $35.8 $1,225 - $2,183
61 Added 0.42%
14,738 $309,000
Q2 2022

Jul 25, 2022

SELL
$27.42 - $43.63 $90,924 - $144,677
-3,316 Reduced 18.43%
14,677 $456,000
Q1 2022

Apr 21, 2022

SELL
$36.48 - $52.22 $14,591 - $20,888
-400 Reduced 2.17%
17,993 $739,000
Q4 2021

Feb 01, 2022

BUY
$33.11 - $55.01 $80,291 - $133,399
2,425 Added 15.19%
18,393 $800,000
Q3 2021

Oct 19, 2021

BUY
$50.07 - $66.05 $23,633 - $31,175
472 Added 3.05%
15,968 $800,000
Q2 2021

Jul 23, 2021

BUY
$56.61 - $80.46 $34,984 - $49,724
618 Added 4.15%
15,496 $976,000
Q4 2020

Feb 09, 2021

SELL
$79.17 - $111.47 $18,525 - $26,083
-234 Reduced 1.55%
14,878 $1.33 Million
Q3 2020

Nov 03, 2020

SELL
$81.91 - $134.94 $208,952 - $344,231
-2,551 Reduced 14.44%
15,112 $1.56 Million
Q1 2020

Apr 20, 2020

SELL
$49.34 - $68.76 $14,802 - $20,628
-300 Reduced 1.67%
17,663 $1.02 Million
Q2 2019

Jul 16, 2019

BUY
$39.92 - $53.86 $23,952 - $32,316
600 Added 3.46%
17,963 $868,000
Q1 2019

May 07, 2019

BUY
$48.23 - $66.16 $15,144 - $20,774
314 Added 1.84%
17,363 $877,000
Q4 2018

Feb 07, 2019

SELL
$55.63 - $73.24 $55.3 Million - $72.8 Million
-993,616 Reduced 98.31%
17,049 $1.01 Million
Q4 2018

Feb 05, 2019

BUY
$55.63 - $73.24 $56.2 Million - $74 Million
1,010,665 New
1,010,665 $17,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $420M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Oregon Public Employees Retirement Fund Portfolio

Follow Oregon Public Employees Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.